Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice

Acta Pharmaceutica

Volumn 59, Issue 2, 2009, Pages 133-144

  Atyabi, Fatemeh ^a   Farkhondehfai, Anahita ^b   Esmaeili, Farnaz ^a   Dinarvand, Rassoul ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Biodistribution; Drug delivery; Nanoparticles; PEG; Pegylated liposomes; SN 38

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; DISTEAROYLPHOSPHATIDYLCHOLINE; DISTEAROYLPHOSPHATIDYLETHANOLAMINE; ETHANOLAMINE DERIVATIVE; LIPOSOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; DRUG SYNTHESIS; ENCAPSULATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY;

EID: 67651180631     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-009-0020-0     Document Type: Article

References (26)

1. F. Ahmed, V. Vyas, S. Goodin, T. S. Ravikumar, E. H. Rubin and E. Gupta, In vitro activation of Irinotecan to SN-38 by human liver and intestine, Anticancer Res. 19 (1999) 2067-2071.
2. rd ed. Lippincott Williams & Wilkins, Philadelphia 2001, pp. 579-646.
3. R. M. Wadkins, P. M. Potter, B. Vladu, J. Marty, G. Mangold, S. Weitman, G. Manikumar, M. C. Wani, M. E. Wall and D. D. Von Hoff, Water soluble 20(S)-glycinate ester of 10,11-methylene-dioxycamptothecins are highly active against human breast cancer xenografts, Cancer Res. 59 (1999) 3424-3428.
4. S. Anabousi, M. Laue, C. M. Lehr, U. Bakowsky and C. Ehrhardt, Assessing transferrin modification of liposomes by atomic force microscopy and transmission electron microscopy, Eur. J. Pharm. Biopharm. 60 (2005) 295-303; DOI: 10.1016/j.ejpb.2004.12.009.
5. S. A. Abraham, D. N. Waterhouse, L. D. Mayer, P. R. Cullis, T. D. Madden and M. B. Bally, The liposomal formulation of doxorubicin, Methods Enzymol. 391 (2005) 71-97; DOI: 10.1016/S0076--6879(05)91004-5.
6. S. P. Vyas, S. Quraishi, S. Gupta and K. S. Jaganathan, Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages, Int. J. Pharm. 296 (2005) 2-25; DOI: 10.1016/j.ijpharm. 2005.02.003.
7. H. Iinuma, K. Maruyama, K. Okinaga, K. Sasaki, T. Sekine, O. Ishida, N. Ogiwara, K. Johkura and Y. Yonemura, Intracellular targeting therapy of cisplatin-encapsulated transferring-polyethyl-eneglycol liposome on peritoneal dissemination of gastric cancer, Int. J. Cancer 99 (2002) 130-137; DOI: 10.1002/ijc.10242.
8. R. J. Hong and Y. L. Tseng, Phase I and pharmacokinetic study of a stable, polyethylene-glyco-lated liposomal doxorubicin in partients with solid tumors, Cancer 91 (2001) 1826-1833; DOI: 10.1002/1097- 0142(20010501)91:9:<1826::AID-CNR1203>3.0.CO,2-J.
9. N. Oku, K. Doi, Y. Namba and S. Okada, Therapeutic effect of adriamycin encapsulated in long-circulating liposomes on Meth-A-sarcoma-bearing mice, Int. J. Cancer 58 (1994) 415-419; DOI: 10.1002/ijc.2910580318.
10. Y. Tokudome, N. Oku, K. Doi, Y. Namba and S. Okada, Antitumor activity of vincristin encapsulated in glucuronide-modified long-circulating liposomes in mice bearing Meth A sarcoma, Biochim. Biophys. Acta 1279 (1996) 70-74; DOI: 10.1016/005-2736(95)00242-1.
11. G. L. Berestein, L. Kasi, M. G. Rosemblum, T. Haynie M. Jahns, H. Glenn, R. Mehta, G. M. Mav-light and E. M. Hersh, Clinical pharmacology of 99mTc-labeled liposomes in patients with cancer, Cancer Res. 44 (1984) 375-378.
12. K. Shimada, A. Miyagishima, Y. Sadzuka, Y. Nozawa and S. Hirota, Determination of the thickness of fixed aqueous layer around the polyethleneglycol-coated liposomes, J. Drug Target. 3 (1995) 283-289.
13. T. Yuda, Y. Pongpaibul, K. Maruyama and M. Iwatatsuru, Prolongation of liposome circulation time by various derivatives of polyethyleneglycols, Bio. Pharm. Bull. 19 (1996) 1347-1351.
14. V. P. Torchilin, V. G. Omelyanenko, M. I. Papisov, A. A. Bogdanov, V. S. Trubetsloy, J. N. Herron and C. A. Gentry, Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity, Biochem. Biophys. Acta 1195 (1994) 11-20; DOI: 10.1016/005-2736(94) 90003-5.
15. J. Janzen, X. Song and D. E. Brooks, Interfacial thickness of liposomes containing poly(ethylene glycol)-cholesterol from electrophoresis, Biophys. J. 70 (1996) 313-320; DOI: 10.1016/S0006-3495 (96)79572-3.
16. A. A. Gabizon, H. Shameeda and S. Zalpisky, Pros and cons of the liposome platform in cancer drug targeting, J. Liposome Res. 16 (2006) 175-183; DOI: 10.1080/08982100600848769.
17. Y. Sadzuka, H. Takabe and T. Sonobe, Liposomalization of SN-38 as active metabolite of CPT-11, J. Control. Rel. 108 (2005) 453-459; DOI: 10.1016/j.jconrel.2005.08.023.
18. A. L. Klibanov, K. Maruyama, V. P. Torchilin and L. Huang, Amphipatic polyethyleneglycols effectively prolong the circulation time of liposomes, FEBS. J. 268 (1990) 235-237; DOI: 10.1016/0014--5793(90)81016-H.
19. T. Xuana, J. A. Zhang and I. Ahmad, HPLC method for determination of SN-38 content and SN-38 entrapment efficiency in a novel liposome-based formulation, LE-SN-38, J. Pharm. Biomed. Anal. 41 (2006) 582-588; DOI: 10.1016/j.jpba.2005.10.051.
20. E. B. Denkbas, X. Kaitianm, A. Tuncel and E. Piskin, Rifampicin-carrying poly(D,L-lactide) microspheres: loading and release, J. Biomat. Sci-Polym. Ed. 6 (1995) 815-825; DOI: 10.1163/ 156856295X00201.
21. K. Yoncheva, E. Lizarraga and J. M. Irache, Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): preparation and evaluation of their bioadhesive properties, Eur. J. Pharm. Sci. 24 (2005) 411-419; DOI: 10.1016/j.ejps.2004.12.002.
22. F. Esmaeili, M. H. Ghahremani, B. Esmaeili, M. R. Khoshayand, F. Atyabi and R. Dinarvand, PLGA nanoparticles of different surface properties: Preparation and evaluation of their body distribution, Int. J. Pharm. 349 (2008) 249-55; DOI: 10.1016/j.ijpharm.2007.07.038.
23. J. M. Harris, N. E. Martin and M. Modi, Pegylation: A novel process for modifying pharma-cokinetics, Clin. Pharmacokinet. 40 (2001) 539-551.
24. L. Mu and S. S. Feng, Vitamin E TPGS used as emulsi.er in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxols), J. Control. Rel. 80 (2002) 129-144; DOI: 10.1016/S0168-3659(02)00025-1.
25. C. Dubernet, Thermoanalysis of microspheres, Thermochim. Acta 248 (1995) 259-269; DOI; 10.1016/0040-6031(94)01947-F.
26. B. Magenheim, M. Y. Levy and S. Benita, A new in vitro technique for evaluation of drug release profile from colloidal carriers-ultrafiltration technique at low pressure, Int. J. Pharm. 94 (1993) 115-123; DOI: 10.1016/0378-5173(93)90015-8.